CEOI MEMBER SINCE 2020

Dr. Vas Narasimhan is CEO of Novartis, one of the world’s most innovative medicines companies, since 2018. During his career at Novartis, he has overseen the licensure of more than 30 novel medicines, including cell and gene, siRNA, and radioligand therapies. Dr. Narasimhan has led a strategic and cultural transformation to bring Novartis into its next era as a fully focused medicines company, delivering medicines that alleviate society’s greatest disease burdens, like cancer and cardiovascular disease, through technology leadership in R&D and novel access approaches. Novartis has completed more than $100 billion in transactions since Dr. Narasimhan became CEO. He has focused his education and career on improving human health and on his personal purpose of inspiring a healthier world. During and after his medical studies, he worked on public health issues, such as HIV/AIDS, malaria, and tuberculosis, in India, Africa, and South America. He continues to champion access and global health priorities, including through a commitment by Novartis to expand access to innovative medicines in low- and middle-income countries by at least 200% by 2025. Dr. Narasimhan is a member of the National Academy of Medicine and serves on the board of African Parks, a nonprofit conservation organization. He has been recognized as one of the Top Global Influencers on LinkedIn, where he shares his personal journey to reimagine medicine and leadership.